R Hayoz, N Vietti-Violi, R Duran, JF Knebel… - European …, 2020 - Springer
Objectives To compare the diagnostic accuracy of dynamic contrast-enhanced phases, hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver …
W Fan, X Yang, F Huang, X Tong… - Oncology …, 2019 - spandidos-publications.com
The mannose receptor (CD206) functions in endocytosis and phagocytosis, and plays an important role in immune homeostasis. Tumor‑associated macrophages express high level …
M Ingenerf, C Auernhammer, R Lorbeer… - Radiology and …, 2024 - sciendo.com
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM Page 1 Radiology and Oncology | Ljubljana …
Neuroendocrine tumors (NET) are a group of neoplasms with neuroendocrine differentiation affecting a wide range of organs. Functional NETs present with symptoms due to the …
A Horng, M Ingenerf, F Berger, D Steffinger… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Background The study aimed to compare and correlate morphological and functional parameters in pancreatic neuroendocrine tumors (pNET) and their synchronous liver …
J Assouline, R Cannella, G Porrello… - Radiology: Imaging …, 2023 - pubs.rsna.org
Purpose To investigate whether liver enhancing tumor burden (LETB) assessed at contrast- enhanced CT indicates early response and helps predict survival outcomes in patients with …
M Barat, P Soyer, F Al Sharhan, B Terris, A Oudjit… - …, 2021 - karger.com
Objectives: The aim of the study was to discriminate hepatic metastases from pancreatic neuroendocrine tumors (pNET) and hepatic metastases from midgut neuroendocrine tumors …
M Miszczuk, J Chapiro, D Do Minh… - Cardiovascular and …, 2022 - Springer
Purpose To assess the value of quantitative analysis of tumor burden on baseline MRI for prediction of survival in patients with neuroendocrine tumor liver metastases (NELM) …